Home > Journals > Journal of Neurosurgical Sciences > Past Issues > Journal of Neurosurgical Sciences 2016 September;60(3) > Journal of Neurosurgical Sciences 2016 September;60(3):350-6

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints
Cite this article as

JOURNAL OF NEUROSURGICAL SCIENCES

A Journal on Neurosurgery


Indexed/Abstracted in: e-psyche, EMBASE, PubMed/MEDLINE, Neuroscience Citation Index, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,522


eTOC

 

REVIEWS  


Journal of Neurosurgical Sciences 2016 September;60(3):350-6

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Rationale for intraoperative radiotherapy in glioblastoma

Frank A. GIORDANO 1, Frederik WENZ 1, Kevin PETRECCA 2

1 Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; 2 Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal, Canada


PDF  


Glioblastoma is the most common and aggressive adult primary brain cancer. Despite multimodal therapy, it is associated with a survival of less than two years. Greater than 85% of recurrences occur within the original area of surgery and radiotherapy, suggesting a potential for improved local treatments. In addition to cancer cell invasion beyond surgical margins, a plethora of postinjury pro-proliferative stimuli are released from local healing brain, which both protect and nourish remaining cancer cells. This review compiles preclinical and clinical evidence for a dedicated treatment of both residual cancer cells and regional microenvironment using intraoperative radiotherapy (IORT).

top of page

Publication History

Cite this article as

Giordano FA, Wenz F, Petrecca K. Rationale for intraoperative radiotherapy in glioblastoma. J Neurosurg Sci 2016 September;60(3):350-6. 

Corresponding author e-mail

frank.giordano@umm.de